Literature DB >> 14984919

Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction.

Marianne Zeller1, Yves Cottin, Marie-Claude Brindisi, Gilles Dentan, Yves Laurent, Luc Janin-Manificat, Isabelle L'Huillier, Jean-Claude Beer, Claude Touzery, Hamid Makki, Bruno Verges, Jean-Eric Wolf.   

Abstract

OBJECTIVES: In-hospital outcome after acute myocardial infarction (MI) has not yet been evaluated with regard to the new category of Impaired Fasting Glucose level (IFG) patients defined by the American Diabetes Association (ADA).
METHODS: Nine hundred and ninety-nine patients with acute MI from the RICO survey were included in the study. Fasting blood glucose was measured after admission. Patients were grouped according to ADA definitions: Diabetes Mellitus (DM) (FG >/=7mmol/l or personal history of DM); IFG (FG 6.1 to 7mmol/l); NFG (normal FG <6.1mmol/l).
RESULTS: Three hundred and eighty-one patients (38%) had DM, 145 (15%) IFG and 473 (47%) NFG. Mortality in the IFG group was twice that of the NFG group (8% vs 4%, P=0.049). A significant increase in cardiogenic shock (12% vs 6%, P=0.011) and ventricular arrhythmia (15% vs 9%, P=0.035) was observed in the IFG vs NFG group. IFG, after adjustment for confounding factors (age, sex, anterior location, and LVEF), was a strong independent predictive factor for cardiogenic shock (P=0.005).
CONCLUSION: MI patients with IFG had an overall worse outcome, characterized by a higher risk of developing cardiogenic shock during their hospital stay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984919     DOI: 10.1016/j.ehj.2003.12.014

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Conventional insulin vs insulin infusion therapy in acute coronary syndrome diabetic patients.

Authors:  Caterina Arvia; Valeria Siciliano; Kyriazoula Chatzianagnostou; Gillian Laws; Alfredo Quinones Galvan; Chiara Mammini; Sergio Berti; Sabrina Molinaro; Giorgio Iervasi
Journal:  World J Diabetes       Date:  2014-08-15

2.  Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study.

Authors:  Z Kadri; N Danchin; L Vaur; Y Cottin; P Guéret; M Zeller; J-M Lablanche; D Blanchard; G Hanania; N Genès; J-P Cambou
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

Review 3.  Stress hyperglycemia and enhanced sensitivity to myocardial infarction.

Authors:  Keith A Webster
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

4.  Relationship between fasting glucose levels and in-hospital mortality in Chinese patients with acute myocardial infarction and diabetes mellitus: a retrospective cohort study.

Authors:  Hao Liang; Yi Chen Guo; Li Ming Chen; Min Li; Wei Zhong Han; Xu Zhang; Shi Liang Jiang
Journal:  BMC Cardiovasc Disord       Date:  2016-08-02       Impact factor: 2.298

5.  Environmental noise exposure is associated with atherothrombotic risk.

Authors:  Magali Koczorowski; Nadine Bernard; Frédéric Mauny; Frederic Chagué; Sophie Pujol; Maud Maza; Yves Cottin; Marianne Zeller
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

6.  Prevalence, Characteristics, and In-Hospital Outcomes of Metabolic Syndrome among Patients with Acute Coronary Syndrome in the United Arab Emirates.

Authors:  Abdulla Shehab; Bayan Al-Dabbagh; Wael Almahmeed; Nazar Bustani; Nicolaas Nagelkerke; Abdulla Alnaeemi; Alawi A Alsheikh-Ali
Journal:  Open Cardiovasc Med J       Date:  2012-07-13

7.  Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction.

Authors:  Alexandre Cochet; Marianne Zeller; Alain Lalande; Isabelle L'huillier; Paul M Walker; Claude Touzery; Bruno Verges; Jean-Eric Wolf; François Brunotte; Yves Cottin
Journal:  J Cardiovasc Magn Reson       Date:  2008-01-15       Impact factor: 5.364

8.  Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation.

Authors:  Xavier Bemtgen; Jonathan Rilinger; Markus Jäckel; Viviane Zotzmann; Alexander Supady; Christoph Benk; Christoph Bode; Tobias Wengenmayer; Achim Lother; Dawid L Staudacher
Journal:  Clin Res Cardiol       Date:  2021-05-04       Impact factor: 5.460

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.